Abbott India
ABBOTINDIA · Pharma > Pharmaceuticals & Drugs · Chairman: Munir Shaikh Listing date: Jan. 9, 2010 · Employees: 3585 · Mumbai · http://www.abbott.co.in

Stock Price vs Company Growth
1d
1.4%
1w
2.7%
1m
2.7%
3m
6.2%
6m
18.0%
1y
4.8%
5y
13.9%
10y
18.3%
all
26.3%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 28,101 1.4%
27,422
30,598
Company Overview

Sales
6,714 Cr
Growth: 10.1%
Profit after Tax
1,509 Cr
Growth: 3.9%
Large Cap
59,713 Cr
P/E: 39.6x
Industry P/E: 32.9x
Fundamentals

Sales (Cr) ₹ 6,714
Growth 10.1%
EBITDA 27.0%
P/S 8.9x
Dividend 1.4%
P/E 39.6x
Book Value ₹ 2,360
PEG Ratio 4.0x
ROE 32.5%
P/B 12.1x
Shareholding Pattern

Institutions
Life Insurance Corporation Of India
1.64 %
Promoters
Abbott Capital India Limited
50.44 %
Abbott Healthcare Products Limited
17.62 %
British Colloids Limited
6.92 %
Others
Increase    Decrease    No change
Company Profile Detailed

The company is one of the leading multinational pharmaceutical companies in India and operates with owned manufacturing units and various independent contract/third party manufacturers based across the country. The company sells its products through independent distributors primarily within India.Products and Services offered by the companyCardiovascular- Keeping heart healthy with breakthrough medical technologies.Diabetes- Helping people with diabetes enjoy healthier, active lives.
Investors (50)
Followers (16)